IBDEI1IZ ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,25494,0)
 ;;=J32.9^^124^1247^118
 ;;^UTILITY(U,$J,358.3,25494,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25494,1,3,0)
 ;;=3^Sinusitis, chronic
 ;;^UTILITY(U,$J,358.3,25494,1,4,0)
 ;;=4^J32.9
 ;;^UTILITY(U,$J,358.3,25494,2)
 ;;=^5008207
 ;;^UTILITY(U,$J,358.3,25495,0)
 ;;=A49.01^^124^1247^72
 ;;^UTILITY(U,$J,358.3,25495,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25495,1,3,0)
 ;;=3^Methicillin Susceptible Staphylococcus Aureus Infection
 ;;^UTILITY(U,$J,358.3,25495,1,4,0)
 ;;=4^A49.01
 ;;^UTILITY(U,$J,358.3,25495,2)
 ;;=^5000235
 ;;^UTILITY(U,$J,358.3,25496,0)
 ;;=R61.^^124^1247^131
 ;;^UTILITY(U,$J,358.3,25496,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25496,1,3,0)
 ;;=3^Sweats/Night Sweats
 ;;^UTILITY(U,$J,358.3,25496,1,4,0)
 ;;=4^R61.
 ;;^UTILITY(U,$J,358.3,25496,2)
 ;;=^331970
 ;;^UTILITY(U,$J,358.3,25497,0)
 ;;=A51.0^^124^1247^132
 ;;^UTILITY(U,$J,358.3,25497,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25497,1,3,0)
 ;;=3^Syphilis genital, primary
 ;;^UTILITY(U,$J,358.3,25497,1,4,0)
 ;;=4^A51.0
 ;;^UTILITY(U,$J,358.3,25497,2)
 ;;=^5000272
 ;;^UTILITY(U,$J,358.3,25498,0)
 ;;=A51.5^^124^1247^133
 ;;^UTILITY(U,$J,358.3,25498,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25498,1,3,0)
 ;;=3^Syphilis,Early Latent
 ;;^UTILITY(U,$J,358.3,25498,1,4,0)
 ;;=4^A51.5
 ;;^UTILITY(U,$J,358.3,25498,2)
 ;;=^266730
 ;;^UTILITY(U,$J,358.3,25499,0)
 ;;=A52.8^^124^1247^134
 ;;^UTILITY(U,$J,358.3,25499,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25499,1,3,0)
 ;;=3^Syphilis,Late Latent
 ;;^UTILITY(U,$J,358.3,25499,1,4,0)
 ;;=4^A52.8
 ;;^UTILITY(U,$J,358.3,25499,2)
 ;;=^266779
 ;;^UTILITY(U,$J,358.3,25500,0)
 ;;=A52.9^^124^1247^136
 ;;^UTILITY(U,$J,358.3,25500,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25500,1,3,0)
 ;;=3^Syphilis,Tertiary
 ;;^UTILITY(U,$J,358.3,25500,1,4,0)
 ;;=4^A52.9
 ;;^UTILITY(U,$J,358.3,25500,2)
 ;;=^5000308
 ;;^UTILITY(U,$J,358.3,25501,0)
 ;;=A52.3^^124^1247^135
 ;;^UTILITY(U,$J,358.3,25501,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25501,1,3,0)
 ;;=3^Syphilis,Neurosyphilis
 ;;^UTILITY(U,$J,358.3,25501,1,4,0)
 ;;=4^A52.3
 ;;^UTILITY(U,$J,358.3,25501,2)
 ;;=^5000298
 ;;^UTILITY(U,$J,358.3,25502,0)
 ;;=J03.90^^124^1247^138
 ;;^UTILITY(U,$J,358.3,25502,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25502,1,3,0)
 ;;=3^Tonsillitis, acute, unspecified
 ;;^UTILITY(U,$J,358.3,25502,1,4,0)
 ;;=4^J03.90
 ;;^UTILITY(U,$J,358.3,25502,2)
 ;;=^5008135
 ;;^UTILITY(U,$J,358.3,25503,0)
 ;;=A15.0^^124^1247^142
 ;;^UTILITY(U,$J,358.3,25503,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25503,1,3,0)
 ;;=3^Tuberculosis, pulmonary
 ;;^UTILITY(U,$J,358.3,25503,1,4,0)
 ;;=4^A15.0
 ;;^UTILITY(U,$J,358.3,25503,2)
 ;;=^5000062
 ;;^UTILITY(U,$J,358.3,25504,0)
 ;;=R76.11^^124^1247^141
 ;;^UTILITY(U,$J,358.3,25504,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25504,1,3,0)
 ;;=3^Tuberculosis, latent
 ;;^UTILITY(U,$J,358.3,25504,1,4,0)
 ;;=4^R76.11
 ;;^UTILITY(U,$J,358.3,25504,2)
 ;;=^5019570
 ;;^UTILITY(U,$J,358.3,25505,0)
 ;;=A15.8^^124^1247^140
 ;;^UTILITY(U,$J,358.3,25505,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25505,1,3,0)
 ;;=3^Tuberculosis NEC
 ;;^UTILITY(U,$J,358.3,25505,1,4,0)
 ;;=4^A15.8
 ;;^UTILITY(U,$J,358.3,25505,2)
 ;;=^266093
 ;;^UTILITY(U,$J,358.3,25506,0)
 ;;=J06.9^^124^1247^143
 ;;^UTILITY(U,$J,358.3,25506,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25506,1,3,0)
 ;;=3^URI/Cold Symptoms
 ;;^UTILITY(U,$J,358.3,25506,1,4,0)
 ;;=4^J06.9
 ;;^UTILITY(U,$J,358.3,25506,2)
 ;;=^5008143
 ;;^UTILITY(U,$J,358.3,25507,0)
 ;;=N34.2^^124^1247^145
 ;;^UTILITY(U,$J,358.3,25507,1,0)
 ;;=^358.31IA^4^2
